Abstract
Pediatric-specific studies on Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are lacking. The objective of this study was to characterize demographics, comorbidities, and outcomes of pediatric SJS and TEN patients on a national level. On average, pediatric SJS/TEN patients were hospitalized longer and had higher mortality rates compared to reports in most previous studies. Better access to dermatologic and multidisciplinary care may help improve pediatric outcomes, although these findings must be corroborated in future studies on larger pediatric populations with SJS and TEN.
References
Antoon JW, Goldman JL, Lee B et al (2018) Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Pediatr Dermatol 35(2):182–187
Hsu DY, Brieva J, Silverberg NB et al (2017) Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. J Am Acad Dermatol 76(5):811–817
Ramien M, Goldman JL (2020) Pediatric SJS-TEN: where are we now? F1000Res 9:982–993.
Quirke KP, Beck A, Gamelli RL et al (2015) A 15-year review of pediatric toxic epidermal necrolysis. J Burn Care Res 36(1):130–136
Finkelstein Y, Soon GS, Acuna P et al (2011) Recurrence and outcomes of Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Pediatrics 128(4):723–728
Messenger E, Kovarik CL, Lipoff JB (2016) Access to inpatient dermatology care in Pennsylvania hospitals. Cutis 97(1):49–51
Acknowledgements
This study was not funded.
Author information
Authors and Affiliations
Contributions
All authors contributed substantially to the production of this manuscript. Study concept and design: SRL. Acquisition of data: ADD. Analysis and interpretation of data: JMF, ADD, SRL. Drafting of the manuscript: JMF, ADD. Critical revision of the manuscript for important intellectual content: SRL. Study supervision: SRL.
Corresponding author
Ethics declarations
Conflict of interest
Ms. Falotico and Mr. Desai have no conflicts of interest. Dr. Lipner has served as a consultant for Ortho Dermatologics, Hoth Therapeutics, and BelleTorus Corporation.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Falotico, J.M., Desai, A.D. & Lipner, S.R. Pediatric Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: a national analysis of 2016 Kids’ Inpatient Database. Arch Dermatol Res 315, 653–656 (2023). https://doi.org/10.1007/s00403-022-02414-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-022-02414-3